Dietary Phytochemicals: Natural Swords Combating Inflammation and Oxidation-Mediated Degenerative Diseases

Oxidative Medicine and Cellular Longevity

Volumn 2016, Issue , 2016, Pages

  Islam, Md Asiful ^a   Alam, Fahmida ^a   Solayman, Md ^b   Khalil, Md Ibrahim ^a,b   Kamal, Mohammad Amjad ^c,d,e   Gan, Siew Hua ^a  

^a SCHOOL OF MEDICAL SCIENCES   (Malaysia)

^b JAHANGIRNAGAR UNIVERSITY   (Bangladesh)

^c KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^d Enzymoics   (Australia)

^e Global Community Educational Foundation   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASES; METABOLITES; OXIDATIVE STRESS;

ACTIVE COMPOUNDS; CARDIOVASCULAR DISEASE; DEGENERATIVE DISEASE; DIABETES MELLITUS; ECONOMIC BURDEN; NATURAL PRODUCTS; POTENTIAL SOURCES; RHEUMATOID ARTHRITIS;

PATHOLOGY;

ANTHOCYANIN; CORDYCEPIN; COUMARIC ACID; EPIDERMAL GROWTH FACTOR; EUGENOL; EXTRA VIRGIN OLIVE OIL; KAEMPFEROL; METHOTREXATE; MILK FAT GLOBULE EPIDERMAL GROWTH FACTOR 8; PHLORIZIN; PLANT MEDICINAL PRODUCT; QUERCETIN DERIVATIVE; RESVERATROL; SULFORAPHANE; UNCLASSIFIED DRUG; ANTIDIABETIC AGENT; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ANTIRHEUMATIC AGENT;

BUTTER; CACAO; CARDIOVASCULAR DISEASE; CINNAMON; DEGENERATIVE DISEASE; DIABETES MELLITUS; FRUIT; HUMAN; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PHYTOCHEMISTRY; POMEGRANATE; RED WINE; REVIEW; RHEUMATOID ARTHRITIS; SESAME; SPICE; TEA; VEGETABLE; ANIMAL; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; DIETARY SUPPLEMENT; DRUG EFFECTS; HEALTHY DIET; INFLAMMATION; ISOLATION AND PURIFICATION; METABOLISM; MORTALITY;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; DIABETES MELLITUS; DIETARY SUPPLEMENTS; HEALTHY DIET; HUMANS; HYPOGLYCEMIC AGENTS; INFLAMMATION; OXIDATIVE STRESS; PHYTOCHEMICALS;

EID: 84990982158     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2016/5137431     Document Type: Review

References (206)

1. T. F. Lüscher, "Ageing, inflammation, and oxidative stress: final common pathways of cardiovascular disease, " European Heart Journal, vol. 36, no. 48, pp. 3381-3383, 2015.
2. A. O. Odegaard, D. R. Jacobs, O. A. Sanchez, D. C. Goff, A. P. Reiner, and M. D. Gross, "Oxidative stress, inflammation, endothelial dysfunction and incidence of type 2 diabetes, " Cardiovascular Diabetology, vol. 15, no. 1, pp. 1-12, 2016.
3. I. B. McInnes and G. Schett, "The pathogenesis of rheumatoid arthritis, "The New England Journal ofMedicine, vol. 365, no. 23, pp. 2205-2219, 2011.
4. D. Mozaffarian, E. J. Benjamin, A. S. Go et al., "Executive summary: heart disease and stroke statistics-2016 update: A report fromthe American Heart Association, " Circulation, vol. 133, no. 4, pp. 447-454, 2016.
5. J. W. Beulens, D. E. Grobbee, and B. Nealb, "The global burden of diabetes and its complications: An emerging pandemic, " European Journal of Cardiovascular Prevention&Rehabilitation, vol. 17, no. 1, supplement, pp. s3-s8, 2010.
6. B. C. Wang, P. Hsu, W. Furnback et al., "Estimating the economic burden of rheumatoid arthritis in Taiwan using the national health insurance database, " Drugs-Real World Outcomes, vol. 3, no. 1, pp. 107-114, 2016.
7. P. Alagona and T. A. Ahmad, "Cardiovascular disease risk assessment and prevention: current guidelines and limitations, " Medical Clinics ofNorthAmerica, vol. 99, no. 4, pp. 711-731, 2015.
8. G. R. Kokil, R. N. Veedu, G. A. Ramm, J. B. Prins, and H. S. Parekh, "Type 2 diabetes mellitus: limitations of conventional therapies and intervention with nucleic acid-based therapeutics, " Chemical Reviews, vol. 115, no. 11, pp. 4719-4743, 2015.
9. K. Albrecht and U. Müller-Ladner, "Side effects and management of side effects of methotrexate in rheumatoid arthritis, " Clinical and Experimental Rheumatology, vol. 28, no. 5, supplement 61, pp. S95-S101, 2010.
10. R. Fischer and O. Maier, "Interrelation of oxidative stress and inflammation in neurodegenerative disease: role of TNF, " Oxidative Medicine and Cellular Longevity, vol. 2015, Article ID 610813, 18 pages, 2015.
11. B. Uttara, A. V. Singh, P. Zamboni, and R. T. Mahajan, "Oxidative stress and neurodegenerative diseases: A review of upstream and downstream antioxidant therapeutic options, " Current Neuropharmacology, vol. 7, no. 1, pp. 65-74, 2009.
12. B. B. Aggarwal, S. Krishnan, and S. Guha, Inflammation, Lifestyle and Chronic Diseases:The Silent Link, CRC Press, New York, NY, USA, 2011.
13. E. Ignatowicz and W. Baer-Dubowska, "Resveratrol, a natural chemopreventive agent against degenerative diseases, " Polish Journal of Pharmacology and Pharmacy, vol. 53, no. 6, pp. 557-569, 2001.
14. S. Ojha, A. Kurdi, B. Sadek et al., "Phytochemicals as prototypes for pharmaceutical leads towards drug development against diabetic cardiomyopathy, " Current Pharmaceutical Design, vol. 22, no. 20, pp. 3058-3070, 2016.
15. M. A. Islam, F. Alam, M. I. Khalil, T. H. Sasongko, andS. H. Gan, "Natural products towards the discovery of potential future antithrombotic drugs, " Current Pharmaceutical Design, vol. 22, no. 20, pp. 2926-2946, 2016.
16. F. Alam, M. A. Islam, S. H. Gan, and M. I. Khalil, "Honey: A potential therapeutic agent for managing diabetic wounds, " Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID169130, 16 pages, 2014.
17. M. A. Winkleby, D. E. Jatulis, E. Frank, and S. P. Fortmann, "Socioeconomic status and health: how education, income, and occupation contribute to risk factors for cardiovascular disease, " American Journal of Public Health, vol. 82, no. 6, pp. 816-820, 1992.
18. P. W. Franks, R. L. Hanson, W. C. Knowler, M. L. Sievers, P. H. Bennett, and H. C. Looker, "Childhood obesity, other cardiovascular risk factors, and premature death, " The New England Journal of Medicine, vol. 362, no. 6, pp. 485-493, 2010.
19. World Health Organization, "Atlas of heart disease and stroke. 2015, " 2015, http://www. who. int/cardiovascular diseases/resources/ atlas/en/.
20. R. B. Singh, S. A. Mengi, Y.-J. Xu, A. S. Arneja, and N. S. Dhalla, "Pathogenesis of atherosclerosis: A multifactorial process, " Experimental and Clinical Cardiology, vol. 7, no. 1, pp. 40-53, 2002.
21. D. Wood, "Established and emerging cardiovascular risk factors, " American Heart Journal, vol. 141, supplement 2, pp. S49-S57, 2001.
22. N. V. Goncharov, P. V. Avdonin, A. D. Nadeev, I. L. Zharkikh, and R. O. Jenkins, "Reactive oxygen species in pathogenesis of atherosclerosis, " Current Pharmaceutical Design, vol. 21, no. 9, pp. 1134-1146, 2015.
23. K. S. McCully, "Homocysteine and the pathogenesis of atherosclerosis, " Expert Review of Clinical Pharmacology, vol. 8, no. 2, pp. 211-219, 2015.
24. R. A. Hegele, "Thegenetic basis of atherosclerosis, " International Journal of Clinical and Laboratory Research, vol. 27, no. 1, pp. 2-13, 1997.
25. C. S. Booker and J. I. Mann, "Trans fatty acids and cardiovascular health: Translation of the evidence base, " Nutrition, Metabolism and Cardiovascular Diseases, vol. 18, no. 6, pp. 448-456, 2008.
26. C. Chrysohoou, D. B. Panagiotakos, C. Pitsavos et al., "The associations between smoking, physical activity, dietary habits and plasma homocysteine levels in cardiovascular disease-free people: The 'ATTICA' study, " VascularMedicine, vol. 9, no. 2, pp. 117-123, 2004.
27. R. Takachi, M. Inoue, J. Ishihara et al., "Fruit and vegetable intake and risk of total cancer and cardiovascular disease Japan PublicHealth Center-based Prospective study, " American Journal of Epidemiology, vol. 167, no. 1, pp. 59-70, 2008.
28. X. Wang, Y. Ouyang, J. Liu et al., "Fruit and vegetable consumption and mortality from all causes, cardiovascular disease, and cancer: systematic review and dose-response meta-analysis of prospective cohort studies, " British Medical Journal, vol. 349, Article ID g4490, pp. 1-14, 2014.
29. X. Gao, O. I. Bermudez, and K. L. Tucker, "Plasma C-reactive protein and homocysteine concentrations are related to frequent fruit and vegetable intake in Hispanic and non-Hispanic white elders, " Journal of Nutrition, vol. 134, no. 4, pp. 913-918, 2004.
30. H. Du, L. Li, D. Bennett et al., "Fresh fruit consumption and major cardiovascular disease in China, " The New England Journal of Medicine, vol. 374, no. 14, pp. 1332-1343, 2016.
31. P. van't Veer, M. C. Jansen, M. Klerk, and F. J. Kok, "Fruits and vegetables in the prevention of cancer and cardiovascular disease, " Public Health Nutrition, vol. 3, no. 1, pp. 103-107, 2000.
32. Y. Nagasako-Akazome, T. Kanda, Y. Ohtake, H. Shimasaki, and T. Kobayashi, "Apple polyphenols influence cholesterol metabolism in healthy subjects with relatively high body mass index, " Journal of Oleo Science, vol. 56, no. 8, pp. 417-428, 2007.
33. X. Yin, J. Quan, and T. Kanazawa, "Banana prevents plasma oxidative stress in healthy individuals, " Plant Foods for Human Nutrition, vol. 63, no. 2, pp. 71-76, 2008.
34. A. Basu, M. Du, M. J. Leyva et al., "Blueberries decrease cardiovascular risk factors in obese men and women with metabolic syndrome, " The Journal of Nutrition, vol. 140, no. 9, pp. 1582-1587, 2010.
35. A. Basu, M. Rhone, and T. J. Lyons, "Berries: emerging impact on cardiovascular health, " Nutrition Reviews, vol. 68, no. 3, pp. 168-177, 2010.
36. I. Erlund, R. Koli, G. Alfthan et al., "Favorable effects of berry consumption on platelet function, blood pressure, and HDL cholesterol, "The American Journal of Clinical Nutrition, vol. 87, no. 2, pp. 323-331, 2008.
37. J. Y. Toh, V. M. H. Tan, P. C. Y. Lim, S. T. Lim, andM. F. F. Chong, "Flavonoids fromfruit and vegetables: A focus on cardiovascular risk factors, " Current Atherosclerosis Reports, vol. 15, no. 12, article 368, pp. 1-7, 2013.
38. C. Morand, C. Dubray, D. Milenkovic et al., "Hesperidin contributes to the vascular protective effects of orange juice: A randomized crossover study in healthy volunteers, " American Journal of Clinical Nutrition, vol. 93, no. 1, pp. 73-80, 2011.
39. S. Rizza, R. Muniyappa, M. Iantorno et al., "Citrus polyphenol hesperidin stimulates production of nitric oxide in endothelial cells while improving endothelial function and reducing inflammatory markers in patients with metabolic syndrome, " The Journal of Clinical Endocrinology &Metabolism, vol. 96, no. 5, pp. E782-E792, 2011.
40. S. Gorinstein, A. Caspi, I. Libman et al., "Red grapefruit positively influences serum triglyceride level in patients suffering from coronary atherosclerosis: studies in vitro and in humans, " Journal of Agricultural and Food Chemistry, vol. 54, no. 5, pp. 1887-1892, 2006.
41. T. Ismail, P. Sestili, and S. Akhtar, "Pomegranate peel and fruit extracts: A review of potential anti-inflammatory and antiinfective effects, " Journal of Ethnopharmacology, vol. 143, no. 2, pp. 397-405, 2012.
42. C. B. Stowe, "The effects of pomegranate juice consumption on blood pressure and cardiovascular health, " Complementary Therapies in Clinical Practice, vol. 17, no. 2, pp. 113-115, 2011.
43. G. Noratto, H. S. D. Martino, S. Simbo, D. Byrne, and S. U. Mertens-Talcott, "Consumption of polyphenol-rich peach and plum juice prevents risk factors for obesity-related metabolic disorders and cardiovascular disease in Zucker rats, " Journal of Nutritional Biochemistry, vol. 26, no. 6, pp. 633-641, 2015.
44. M. Y. Hong, N. Hartig, K. Kaufman, S. Hooshmand, A. Figueroa, and M. Kern, "Watermelon consumption improves inflammation and antioxidant capacity in rats fed an atherogenic diet, " Nutrition Research, vol. 35, no. 3, pp. 251-258, 2015.
45. T. C. Wallace, "Anthocyanins in cardiovascular disease, " Advances in Nutrition, vol. 2, no. 1, pp. 1-7, 2011.
46. M. A. Vazquez-Prieto and R. M. Miatello, "Organosulfur compounds and cardiovascular disease, " Molecular Aspects of Medicine, vol. 31, no. 6, pp. 540-545, 2010.
47. H. S. Chang, O. Yamato, M. Yamasaki, and Y. Maede, "Modulatory influence of sodium 2-propenyl thiosulfate from garlic on cyclooxygenase activity in canine platelets: possiblemechanism for the anti-aggregatory effect, " Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 72, no. 5, pp. 351-355, 2005.
48. J. Terao, Y. Kawai, andK. Murota, "Vegetable flavonoids and cardiovascular disease, " Asia Pacific Journal of Clinical Nutrition, vol. 17, supplement 1, pp. 291-293, 2008.
49. C. P. Bondonno, X. Yang, K. D. Croft et al., "Flavonoid-rich apples and nitrate-rich spinach augment nitric oxide status andimprove endothelial function in healthy men and women: A randomized controlled trial, " Free Radical Biology&Medicine, vol. 52, no. 1, pp. 95-102, 2012.
50. S. Auclair, G. Chironi, D. Milenkovic et al., "The regular consumption of a polyphenol-rich apple does not influence endothelial function: A randomised double-blind trial in hypercholesterolemic adults, " European Journal of Clinical Nutrition, vol. 64, no. 10, pp. 1158-1165, 2010.
51. P. Valderas-Martinez, G. Chiva-Blanch, R. Casas et al., "Tomato sauce enriched with olive oil exerts greater effects on cardiovascular disease risk factors than raw tomato and tomato sauce: A randomized trial, " Nutrients, vol. 8, no. 3, article 170, 2016.
52. F. Squadrito, D. Altavilla, A. Crisafulli et al., "Effect of genistein on endothelial function in postmenopausal women: A randomized, double-blind, controlled study, " The American Journal of Medicine, vol. 114, no. 6, pp. 470-476, 2003.
53. S. Egert, A. Bosy-Westphal, J. Seiberl et al., "Quercetin reduces systolic blood pressure and plasma oxidised low-density lipoprotein concentrations in overweight subjects with a high-cardiovascular disease risk phenotype: A double-blinded, placebo-controlled cross-over study, " British Journal of Nutrition, vol. 102, no. 7, pp. 1065-1074, 2009.
54. S. S. Hassellund, A. Flaa, S. E. Kjeldsen et al., "Effects of anthocyanins on cardiovascular risk factors and inflammation in pre-hypertensive men: A double-blind randomized placebocontrolled crossover study, " Journal of Human Hypertension, vol. 27, no. 2, pp. 100-106, 2013.
55. S. Kianbakht, B. Abasi, and F. Hashem Dabaghian, "Improved lipid profile in hyperlipidemic patients taking Vaccinium arctostaphylos fruit hydroalcoholic extract: A randomized doubleblind placebo-controlled clinical trial, " Phytotherapy Research, vol. 28, no. 3, pp. 432-436, 2014.
56. R. Soltani, M. Hakimi, S. Asgary, S. M. Ghanadian, M. Keshvari, and N. Sarrafzadegan, "Evaluation of the effects of Vaccinium arctostaphylos L. fruit extract on serum lipids and hs-CRP levels and oxidative stress in adult patients with hyperlipidemia: A randomized, double-blind, placebo-controlled clinical trial, " Evidence-Based Complementary and Alternative Medicine, vol. 2014, Article ID217451, 6 pages, 2014.
57. D. Taubert, R. Roesen, C. Lehmann, N. Jung, and E. Schömig, "Effects of low habitual cocoa intake on blood pressure and bioactive nitric oxide: A randomized controlled trial, " The Journal of the American Medical Association, vol. 298, no. 1, pp. 49-60, 2007.
58. Z. Faridi, V. Y. Njike, S. Dutta, A. Ali, and D. L. Katz, "Acute dark chocolate and cocoa ingestion and endothelial function: A randomized controlled crossover trial, " The American Journal of Clinical Nutrition, vol. 88, no. 1, pp. 58-63, 2008.
59. N. M. K. Selvi, M. G. Sridhar, R. P. Swaminathan, and R. Sripradha, "Efficacy of turmeric as adjuvant therapy in type 2 diabetic patients, " Indian Journal of Clinical Biochemistry, vol. 30, no. 2, pp. 180-186, 2015.
60. T. Arablou, N. Aryaeian, M. Valizadeh, F. Sharifi, A. Hosseini, and M. Djalali, "The effect of ginger consumption on glycemic status, lipid profile and some inflammatory markers in patients with type 2 diabetes mellitus, " International Journal of Food Sciences and Nutrition, vol. 65, no. 4, pp. 515-520, 2014.
61. J. Tomé-Carneiro, M. Larrosa, M. J. Yáñez-Gascón et al., "Oneyear supplementation with a grape extract containing resveratrolmodulates inflammatory-related microRNAs and cytokines expression in peripheral blood mononuclear cells of type 2 diabetes and hypertensive patients with coronary artery disease, " Pharmacological Research, vol. 72, pp. 69-82, 2013.
62. S. Moazen, R. Amani, A. Homayouni Rad, H. Shahbazian, K. Ahmadi, and M. Taha Jalali, "Effects of freeze-dried strawberry supplementation on metabolic biomarkers of atherosclerosis in subjects with type 2 diabetes: A randomized double-blind controlled trial, " Annals of Nutrition and Metabolism, vol. 63, no. 3, pp. 256-264, 2013.
63. S. Mahluji, A. Ostadrahimi, M. Mobasseri, V. E. Attari, and L. Payahoo, "Anti-inflammatory effects of Zingiber officinale in type 2 diabetic patients, " Advanced Pharmaceutical Bulletin, vol. 3, no. 2, pp. 273-276, 2013.
64. Z. Bahadoran, P. Mirmiran, F. Hosseinpanah, M. Hedayati, S. Hosseinpour-Niazi, and F. Azizi, "Broccoli sprouts reduce oxidative stress in type 2 diabetes: A randomized double-blind clinical trial, " European Journal of Clinical Nutrition, vol. 65, no. 8, pp. 972-977, 2011.
65. P. Kar, D. Laight, H. K. Rooprai, K. M. Shaw, andM. Cummings, "Effects of grape seed extract in Type 2 diabetic subjects at high cardiovascular risk: A double blind randomized placebo controlled trial examining metabolic markers, vascular tone, inflammation, oxidative stress and insulin sensitivity, " Diabetic Medicine, vol. 26, no. 5, pp. 526-531, 2009.
66. B. Chandran and A. Goel, "A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis, " Phytotherapy Research, vol. 26, no. 11, pp. 1719-1725, 2012.
67. S.-C. Bae, W.-J. Jung, E.-J. Lee, R. Yu, and M.-K. Sung, "Effects of antioxidant supplements intervention on the level of plasma inflammatory molecules and disease severity of rheumatoid arthritis patients, " Journal of the American College of Nutrition, vol. 28, no. 1, pp. 56-62, 2009.
68. C. M. Bitler, K. Matt, M. Irving et al., "Olive extract supplement decreases pain and improves daily activities in adults with osteoarthritis and decreases plasma homocysteine in those with rheumatoid arthritis, " Nutrition Research, vol. 27, no. 8, pp. 470-477, 2007.
69. A. Upaganlawar, V. Patel, and R. Balaraman, "Tomato lycopene attenuates myocardial infarction induced by isoproterenol: electrocardiographic, biochemical and anti-apoptotic study, " Asian Pacific Journal of Tropical Biomedicine, vol. 2, no. 5, pp. 345-351, 2012.
70. B. L. B. Pereira, F. C. O. Arruda, P. P. Reis et al., "Tomato (Lycopersicon esculentum) supplementation induces changes in cardiac miRNA expression, reduces oxidative stress and left ventricular mass, and improves diastolic function, " Nutrients, vol. 7, no. 11, pp. 9640-9649, 2015.
71. H. D. Sesso, S. Liu, J. M. Gaziano, and J. E. Buring, "Dietary lycopene, tomato-based food products and cardiovascular disease in women, " Journal of Nutrition, vol. 133, no. 7, pp. 2336-2341, 2003.
72. R. Grzanna, L. Lindmark, and C. G. Frondoza, "Ginger-an herbal medicinal product with broad anti-inflammatory actions, " Journal ofMedicinal Food, vol. 8, no. 2, pp. 125-132, 2005.
73. M. Thomson, K. K. Al-Qattan, S. M. Al-Sawan, M. A. Alnaqeeb, I. Khan, and M. Ali, "The use of ginger (Zingiber officinale Rosc.) as a potential anti-inflammatory and antithrombotic agent, " Prostaglandins, Leukotrienes and Essential Fatty Acids, vol. 67, no. 6, pp. 475-478, 2002.
74. R. S. Ahmed, V. Seth, and B. D. Banerjee, "Influence of dietary ginger (Zingiber officinales Rosc) on antioxidant defense systemin rat: Comparison with ascorbic acid, " Indian Journal of Experimental Biology, vol. 38, no. 6, pp. 604-606, 2000.
75. A. Bordia, S. K. Verma, and K. C. Srivastava, "Effect of ginger (Zingiber officinale Rosc.) and fenugreek (Trigonella foenumgraecum L.) on blood lipids, blood sugar and platelet aggregation in patients with coronary artery disease, " Prostaglandins Leukotrienes and Essential Fatty Acids, vol. 56, no. 5, pp. 379-384, 1997.
76. M. Kobayashi, Y. Ishida, N. Shoji, and Y. Ohizumi, "Cardiotonic action of [8]-gingerol, an activator of the Ca++-pumping adenosine triphosphatase of sarcoplasmic reticulum, in guinea pig atrial muscle, " Journal of Pharmacology and Experimental Therapeutics, vol. 246, no. 2, pp. 667-673, 1988.
77. M. N. Ghayur and A. H. Gilani, "Ginger lowers blood pressure through blockade of voltage-dependent calcium channels, " Journal of Cardiovascular Pharmacology, vol. 45, no. 1, pp. 74-80, 2005.
78. B. Fuhrman, M. Rosenblat, T. Hayek, R. Coleman, and M. Aviram, "Ginger extract consumption reduces plasma cholesterol, inhibits LDL oxidation and attenuates development of atherosclerosis in atherosclerotic, apolipoprotein E-deficient mice, " Journal of Nutrition, vol. 130, no. 5, pp. 1124-1131, 2000.
79. A. S. Wakade, A. S. Shah, M. P. Kulkarni, and A. R. Juvekar, "Protective effect of Piper longum L. on oxidative stress induced injury and cellular abnormality in adriamycin induced cardiotoxicity in rats, " Indian Journal of Experimental Biology, vol. 46, no. 7, pp. 528-533, 2008.
80. R. S. Vijayakumar, D. Surya, R. Senthilkumar, and N. Nalini, "Hypolipidemic effect of black pepper (Piper nigrum Linn.) in Rats fed high fat diet, " Journal of Clinical Biochemistry and Nutrition, vol. 32, pp. 31-42, 2002.
81. S. Joukar, H. Najafipour, M. Khaksari et al., "The effect of saffron consumption on biochemical and histopathological heart indices of rats withmyocardial infarction, " Cardiovascular Toxicology, vol. 10, no. 1, pp. 66-71, 2010.
82. R. Mehdizadeh, M.-R. Parizadeh, A.-R. Khooei, S. Mehri, and H. Hosseinzadeh, "Cardioprotective effect of saffron extract and safranal in isoproterenol-induced myocardial infarction in wistar rats, " Iranian Journal of BasicMedical Sciences, vol. 16, no. 1, pp. 56-63, 2013.
83. G. K. Jayaprakasha, L. J. M. Rao, and K. K. Sakariah, "Volatile constituents from Cinnamomum zeylanicum fruit stalks and their antioxidant activities, " Journal of Agricultural and Food Chemistry, vol. 51, no. 15, pp. 4344-4348, 2003.
84. Z.-M. Wang, B. Zhou, Y.-S. Wang et al., "Black and green tea consumption and the risk of coronary artery disease: A metaanalysis, " The American Journal of Clinical Nutrition, vol. 93, no. 3, pp. 506-515, 2011.
85. B. Buijsse, E. J. M. Feskens, F. J. Kok, and D. Kromhout, "Cocoa intake, blood pressure, and cardiovascular mortality: The Zutphen Elderly Study, " Archives of Internal Medicine, vol. 166, no. 4, pp. 411-417, 2006.
86. L. Hooper, C. Kay, A. Abdelhamid et al., "Effects of chocolate, cocoa, and flavan-3-ols on cardiovascular health: A systematic review and meta-analysis of randomized trials, " American Journal of Clinical Nutrition, vol. 95, no. 3, pp. 740-751, 2012.
87. R. Corti, A. J. Flammer, N. K. Hollenberg, and T. F. Lüscher, "Cocoa and cardiovascular health, " Circulation, vol. 119, no. 10, pp. 1433-1441, 2009.
88. L. Jia, X. Liu, Y. Y. Bai et al., "Short-termeffect of cocoa product consumption on lipid profile: A meta-analysis of randomized controlled trials, " The American Journal of Clinical Nutrition, vol. 92, no. 1, pp. 218-225, 2010.
89. American Diabetes Association, "Diagnosis and classification of diabetes mellitus, " Diabetes Care, vol. 37, supplement 1, pp. S81-S90, 2013.
90. F. Alam, M. A. Islam, M. I. Khalil, and S. H. Gan, "Metabolic control of type 2 diabetes by targeting the GLUT4 glucose transporter: intervention approaches, " Current Pharmaceutical Design, vol. 22, no. 20, pp. 3034-3049, 2016.
91. B. B. Kahn, "Type 2 diabetes: when insulin secretion fails to compensate for insulin resistance, " Cell, vol. 92, no. 5, pp. 593-596, 1998.
92. M. Y. Donath, "Targeting inflammation in the treatment of type 2 diabetes: Time to start, " Nature Reviews Drug Discovery, vol. 13, no. 6, pp. 465-476, 2014.
93. L. Guariguata, D. R. Whiting, I. Hambleton, J. Beagley, U. Linnenkamp, and J. E. Shaw, "Global estimates of diabetes prevalence for 2013 and projections for 2035, " Diabetes Research and Clinical Practice, vol. 103, no. 2, pp. 137-149, 2014.
94. J. C. Pickup, "Inflammation and activated innate immunity in the pathogenesis of type 2 diabetes, " Diabetes Care, vol. 27, no. 3, pp. 813-823, 2004.
95. S. E. Shoelson, J. Lee, and A. B. Goldfine, "Inflammation and insulin resistance, "The Journal of Clinical Investigation, vol. 116, no. 7, pp. 1793-1801, 2006.
96. E. D. Werner, J. Lee, L. Hansen, M. Yuan, and S. E. Shoelson, "Insulin resistance due to phosphorylation of insulin receptor substrate-1 at serine 302, "The Journal of Biological Chemistry, vol. 279, no. 34, pp. 35298-35305, 2004.
97. Y. Zick, "Ser/Thr phosphorylation of IRS proteins: A molecular basis for insulin resistance, " Science Signaling, vol. 2005, no. 268, article pe4, 2005.
98. D. Cai, M. Yuan, D. F. Frantz et al., "Local and systemic insulin resistance resulting from hepatic activation of IKK-and NF-B, " Nature Medicine, vol. 11, no. 2, pp. 183-190, 2005.
99. U. Asmat, K. Abad, and K. Ismail, "Diabetes mellitus and oxidative stress-a concise review, " Saudi Pharmaceutical Journal, 2015.
100. M. Solayman, Y. Ali, F. Alam et al., "Polyphenols: potential future arsenals in the treatment of diabetes, " Current Pharmaceutical Design, vol. 22, no. 5, pp. 549-565, 2016.
101. D. J. Betteridge, "What is oxidative stress" Metabolism, vol. 49, no. 2, pp. 3-8, 2000.
102. A. N. Murunga, D. O. Miruka, C. Driver, F. S. Nkomo, S. Z. Cobongela, and P. M. Owira, "Grapefruit derived flavonoid naringin improves ketoacidosis and lipid peroxidation in type 1 diabetes rat model, " PLoS ONE, vol. 11, no. 4, Article ID e0153241, pp. 1-16, 2016.
103. A. K. Sharma, S. Bharti, S. Ojha et al., "Up-regulation of PPAR, heat shock protein-27 and-72 by naringin attenuates insulin resistance,-cell dysfunction, hepatic steatosis and kidney damage in a rat model of type 2 diabetes, " British Journal of Nutrition, vol. 106, no. 11, pp. 1713-1723, 2011.
104. C.-C. Chang, C.-Y. Chang, J.-P. Huang, and L.-M. Hung, "Effect of resveratrol on oxidative and inflammatory stress in liver and spleen of streptozotocin-induced type 1 diabetic rats, " Chinese Journal of Physiology, vol. 55, no. 3, pp. 192-201, 2012.
105. S. Sekhon-Loodu, Ziaullah, and H. P. V. Rupasinghe, "Docosahexaenoic acid ester of phloridzin inhibit lipopolysaccharideinduced inflammation in THP-1 differentiated macrophages, " International Immunopharmacology, vol. 25, no. 1, pp. 199-206, 2015.
106. M.Á. Martin, E. Fernández-Millán, S. Ramos, L. Bravo, and L. Goya, "Cocoa flavonoid epicatechin protects pancreatic beta cell viability and function against oxidative stress, " Molecular Nutrition & Food Research, vol. 58, no. 3, pp. 447-456, 2014.
107. S. Banihani, S. Swedan, and Z. Alguraan, "Pomegranate and type 2 diabetes, " Nutrition Research, vol. 33, no. 5, pp. 341-348, 2013.
108. E. M. Seymour, S. K. Lewis, D. E. Urcuyo-Llanes et al., "Regular tart cherry intake alters abdominal adiposity, adipose gene transcription, and inflammation in obesity-prone rats fed a high fat diet, " Journal of Medicinal Food, vol. 12, no. 5, pp. 935-942, 2009.
109. D. F. Garcia-Diaz, M. H. Johnson, and E. G. de Mejia, "Anthocyanins from fermented berry beverages inhibit inflammationrelated adiposity response in vitro, " Journal of Medicinal Food, vol. 18, no. 4, pp. 489-496, 2015.
110. A. D. de la Garza, U. Etxeberria, S. Palacios-Ortega et al., "Modulation of hyperglycemia and TNF-mediated inflammation by helichrysum and grapefruit extracts in diabetic db/db mice, " Food & Function, vol. 5, no. 9, pp. 2120-2128, 2014.
111. Y. Ding, X. Dai, Y. Jiang et al., "Grape seed proanthocyanidin extracts alleviate oxidative stress and ER stress in skeletal muscle of low-dose streptozotocin-and high-carbohydrate/highfat diet-induced diabetic rats, " Molecular Nutrition & Food Research, vol. 57, no. 2, pp. 365-369, 2013.
112. M. R. Chacón, V. Ceperuelo-Mallafré, E. Maymó-Masip et al., "Grape-seed procyanidins modulate inflammation on human differentiated adipocytes in vitro, " Cytokine, vol. 47, no. 2, pp. 137-142, 2009.
113. W. Yin, B. Li, X. Li et al., "Anti-inflammatory effects of grape seed procyanidin B2 on a diabetic pancreas, " Food & Function, vol. 6, no. 9, pp. 3065-3071, 2015.
114. Y.-H. Chen, C.-H. Lee, T.-H. Hsu, and H.-C. Lo, "Submergedculture mycelia and broth of the maitake medicinal mushroom Grifola frondosa (higher basidiomycetes) alleviate type 2 diabetes-induced alterations in immunocytic function, " International Journal ofMedicinalMushrooms, vol. 17, no. 6, pp. 541-556, 2015.
115. C. Li, Q. Ding, S.-P. Nie, Y.-S. Zhang, T. Xiong, and M.-Y. Xie, "Carrot juice fermented with Lactobacillus plantarum NCU116 ameliorates type 2 diabetes in rats, " Journal of Agricultural and Food Chemistry, vol. 62, no. 49, pp. 11884-11891, 2014.
116. Z. Zhang, S. Wang, S. Zhou et al., "Sulforaphane prevents the development of cardiomyopathy in type 2 diabetic mice probably by reversing oxidative stress-induced inhibition of LKB1/AMPK pathway, " Journal of Molecular and Cellular Cardiology, vol. 77, pp. 42-52, 2014.
117. J. Y. Jung, Y. Lim, M. S. Moon, J. Y. Kim, and O. Kwon, "Onion peel extracts ameliorate hyperglycemia and insulin resistance in high fat diet/streptozotocin-induced diabetic rats, " Nutrition & Metabolism, vol. 8, no. 1, article 18, pp. 1-8, 2011.
118. S. Shin, S. Lee, J. Kwon et al., "Cordycepin suppresses expression of diabetes regulating genes by inhibition of lipopolysaccharideinduced inflammation in macrophages, " Immune Network, vol. 9, no. 3, pp. 98-105, 2009.
119. H. Lei, M. Zhang, Q. Wang et al., "MT-glucan from the fruit body of the maitake medicinal mushroom Grifola frondosa (higher Basidiomyetes) shows protective effects for hypoglycemic pancreatic-cells, " International Journal of Medicinal Mushrooms, vol. 15, no. 4, pp. 373-381, 2013.
120. G. Oboh, A. O. Ademosun, A. O. Ademiluyi, O. S. Omojokun, E. E. Nwanna, and K. O. Longe, "In vitro studies on the antioxidant property and inhibition of-amylase,-glucosidase, and angiotensin I-converting enzyme by polyphenol-rich extracts fromcocoa (Theobroma cacao) Bean, " Pathology Research International, vol. 2014, Article ID 549287, 6 pages, 2014.
121. F. Zhang, F. Yang, H. Zhao, and Y. An, "Curcumin alleviates lung injury in diabetic rats by inhibiting nuclear factor-B pathway, " Clinical and Experimental Pharmacology and Physiology, vol. 42, no. 9, pp. 956-963, 2015.
122. L. M. Jiménez-Flores, S. López-Briones, M. H. Macás-Cervantes, J. Ramrez-Emiliano, and V. Pérez-Vázquez, "A PPAR, NF-B and AMPK-dependent mechanism may be involved in the beneficial effects of curcumin in the diabetic db/db mice liver, " Molecules, vol. 19, no. 6, pp. 8289-8302, 2014.
123. T. Ono, S. Takada, S. Kinugawa, and H. Tsutsui, "Curcumin ameliorates skeletal muscle atrophy in type 1 diabetic mice by inhibiting protein ubiquitination, " Experimental Physiology, vol. 100, no. 9, pp. 1052-1063, 2015.
124. P. P. Nahar, A. L. Slitt, and N. P. Seeram, "Anti-inflammatory effects of novel standardized solid lipid curcumin formulations, " Journal of Medicinal Food, vol. 18, no. 7, pp. 786-792, 2015.
125. P. Suryanarayana, A. Satyanarayana, N. Balakrishna, P. U. Kumar, and G. B. Reddy, "Effect of turmeric and curcumin on oxidative stress and antioxidant enzymes in streptozotocininduced diabetic rat, "Medical ScienceMonitor, vol. 13, no. 12, pp. BR286-BR292, 2007.
126. M. Rastogi, R. P. Ojha, G. V. Rajamanickam, A. Agrawal, A. Aggarwal, and G. P. Dubey, "Curcuminoidsmodulates oxidative damage and mitochondrial dysfunction in diabetic rat brain, " Free Radical Research, vol. 42, no. 11-12, pp. 999-1005, 2008.
127. J. Lin, S. Zheng, and A. Chen, "Curcumin attenuates the effects of insulin on stimulating hepatic stellate cell activation by interrupting insulin signaling and attenuating oxidative stress, " Laboratory Investigation, vol. 89, no. 12, pp. 1397-1409, 2009.
128. Y. Pan, G. Zhu, Y. Wang et al., "Attenuation of high-glucoseinduced inflammatory response by a novel curcumin derivative B06 contributes to its protection from diabetic pathogenic changes in rat kidney and heart, " Journal ofNutritional Biochemistry, vol. 24, no. 1, pp. 146-155, 2013.
129. N. F. Abdul Sani, L. K. Belani, C. Pui Sin et al., "Effect of the combination of gelam honey and ginger on oxidative stress and metabolic profile in streptozotocin-induced diabetic spraguedawley rats, " BioMed Research International, vol. 2014, Article ID 160695, 9 pages, 2014.
130. J. Wattanathorn, P. Thiraphatthanavong, S. Muchimapura, W. Thukhammee, K. Lertrat, and B. Suriharn, "The combined extract of Zingiber officinale and Zea mays (purple color) improves neuropathy, oxidative stress, and axon density in streptozotocin induced diabetic rats, " Evidence-Based Complementary and Alternative Medicine, vol. 2015, Article ID 301029, 11 pages, 2015.
131. M. Priya Rani, K. P. Padmakumari, B. Sankarikutty, O. Lijo Cherian, V. M. Nisha, and K. G. Raghu, "Inhibitory potential of ginger extracts against enzymes linked to type 2 diabetes, inflammation and induced oxidative stress, " International Journal of Food Sciences and Nutrition, vol. 62, no. 2, pp. 106-110, 2011.
132. K. R. Shanmugam, K. Mallikarjuna, N. Kesireddy, and K. S. Reddy, "Neuroprotective effect of ginger on anti-oxidant enzymes in streptozotocin-induced diabetic rats, " Food and Chemical Toxicology, vol. 49, no. 4, pp. 893-897, 2011.
133. G. El-Akabawy and W. El-Kholy, "Neuroprotective effect of ginger in the brain of streptozotocin-induced diabetic rats, " Annals of Anatomy, vol. 196, no. 2-3, pp. 119-128, 2014.
134. N. Kota, V. V. Panpatil, R. Kaleb, B. Varanasi, and K. Polasa, "Dose-dependent effect in the inhibition of oxidative stress and anticlastogenic potential of ginger in STZ induced diabetic rats, " Food Chemistry, vol. 135, no. 4, pp. 2954-2959, 2012.
135. H. R. Madkor, S. W. Mansour, and G. Ramadan, "Modulatory effects of garlic, ginger, turmeric and their mixture on hyperglycaemia, dyslipidaemia and oxidative stress in streptozotocinnicotinamide diabetic rats, " British Journal of Nutrition, vol. 105, no. 8, pp. 1210-1217, 2011.
136. S. Samarghandian, M. Azimi-Nezhad, and F. Samini, "Ameliorative effect of saffron aqueous extract on hyperglycemia, hyperlipidemia, and oxidative stress on diabetic encephalopathy in streptozotocin induced experimental diabetes mellitus, " BioMed Research International, vol. 2014, Article ID 920857, 12 pages, 2014.
137. E. Altinoz, Z. Oner, H. Elbe, Y. Cigremis, and Y. Turkoz, "Protective effects of saffron (its active constituent, crocin) on nephropathy in streptozotocin-induced diabetic rats, " Human & Experimental Toxicology, vol. 34, no. 2, pp. 127-134, 2015.
138. Ö. Hazman and S. Oval, "Investigation of the antiinflammatory effects of safranal on high-fat diet and multiple low-dose streptozotocin induced type 2 diabetes rat model, " Inflammation, vol. 38, no. 3, pp. 1012-1019, 2015.
139. K. E. Campos, Y. S. Diniz, A. C. Cataneo, L. A. Faine, M. J. Q. F. Alves, and E. L. B. Novelli, "Hypoglycaemic and antioxidant effects of onion, Allium cepa: dietary onion addition, antioxidant activity and hypoglycaemic effects on diabetic rats, " International Journal of Food Sciences and Nutrition, vol. 54, no. 3, pp. 241-246, 2003.
140. K. Azuma, Y. Minami, K. Ippoushi, and J. Terao, "Lowering effects of onion intake on oxidative stress biomarkers in streptozotocin-induced diabetic rats, " Journal of Clinical Biochemistry and Nutrition, vol. 40, no. 2, pp. 131-140, 2007.
141. M. Bang, H.-A. Kim, and Y.-J. Cho, "Alterations in the blood glucose, serum lipids and renal oxidative stress in diabetic rats by supplementation of onion (Allium cepa. Linn), " Nutrition Research and Practice, vol. 3, no. 3, pp. 242-246, 2009.
142. T. Yokozawa, H. Y. Kim, E. J. Cho, N. Yamabe, and J. S. Choi, "Protective effects of mustard leaf (Brassica juncea) against diabetic oxidative stress, " Journal of Nutritional Science and Vitaminology, vol. 49, no. 2, pp. 87-93, 2003.
143. F. Haidari, M. Mohammadshahi, M. Zarei, andZ. Gorji, "Effects of sesame butter (Ardeh) versus sesame oil on metabolic and oxidative stress markers in streptozotocin-induced diabetic rats, " Iranian Journal ofMedical Sciences, vol. 41, no. 2, pp. 102-109, 2016.
144. T. Baluchnejadmojarad, M. Roghani, M.-R. Jalali Nadoushan et al., "The sesame lignan sesamin attenuates vascular dysfunction in streptozotocin diabetic rats: involvement of nitric oxide and oxidative stress, " European Journal of Pharmacology, vol. 698, no. 1-3, pp. 316-321, 2013.
145. S. N. Prasad, M. S. Bharath, andMuralidhara, "Neurorestorative effects of eugenol, a spice bioactive: evidence in cell model and its efficacy as an intervention molecule to abrogate brain oxidative dysfunctions in the streptozotocin diabetic rat, " Neurochemistry International, vol. 95, pp. 24-36, 2016.
146. S. A. Adefegha, G. Oboh, O. M. Adefegha, A. A. Boligon, andM. L. Athayde, "Antihyperglycemic, hypolipidemic, hepatoprotective and antioxidative effects of dietary clove (Szyzgium aromaticum) bud powder in a high-fat diet/streptozotocininduced diabetes rat model, " Journal of the Science of Food and Agriculture, vol. 94, no. 13, pp. 2726-2737, 2014.
147. A. G. Jagtap and P. B. Patil, "Antihyperglycemic activity and inhibition of advanced glycation end product formation by Cuminum cyminum in streptozotocin induced diabetic rats, " Food and Chemical Toxicology, vol. 48, no. 8-9, pp. 2030-2036, 2010.
148. M.-C. Boissier, L. Semerano, S. Challal, N. Saidenberg-Kermanac'h, and G. Falgarone, "Rheumatoid arthritis: fromautoimmunity to synovitis and joint destruction, " Journal of Autoimmunity, vol. 39, no. 3, pp. 222-228, 2012.
149. J. S. Smolen, D. Aletaha, M. Koeller, M. H. Weisman, and P. Emery, "New therapies for treatment of rheumatoid arthritis, " The Lancet, vol. 370, no. 9602, pp. 1861-1874, 2007.
150. S. Shiozawa and K. Tsumiyama, "Pathogenesis of rheumatoid arthritis and c-Fos/AP-1, " Cell Cycle, vol. 8, no. 10, pp. 1539-1543, 2009.
151. H. B. Sun, "Mechanical loading, cartilage degradation, and arthritis, " Annals of the New York Academy of Sciences, vol. 1211, no. 1, pp. 37-50, 2010.
152. D. L. Scott, F. Wolfe, and T. W. J. Huizinga, "Rheumatoid arthritis, " The Lancet, vol. 376, no. 9746, pp. 1094-1108, 2010.
153. N. Vivar and R. F. Van Vollenhoven, "Advances in the treatment of rheumatoid arthritis, " F1000Prime Reports, vol. 6, no. 31, pp. 1-9, 2014.
154. J. A. Rindfleisch and D. Muller, "Diagnosis and management of rheumatoid arthritis, " American Family Physician, vol. 72, no. 6, pp. 1037-1047, 2005.
155. G. Schmajuk, A. N. Trivedi, D. H. Solomon et al., "Receipt of disease-modifying antirheumatic drugs among patients with rheumatoid arthritis in medicare managed care plans, " The Journal of the AmericanMedical Association, vol. 305, no. 5, pp. 480-486, 2011.
156. K. A. Theis, C. G. Helmick, and J. M. Hootman, "Arthritis burden and impact are greater among U. S. women than men: intervention opportunities, " Journal of Women's Health, vol. 16, no. 4, pp. 441-453, 2007.
157. K. E. Barbour, C. G. Helmick, K. A. Theis et al., "Prevalence of doctor-diagnosed arthritis and arthritis-attributable activity limitation-United States, " Morbidity and Mortality Weekly Report, vol. 62, no. 44, pp. 869-873, 2013.
158. J. M. Hootman and C. G. Helmick, "Projections of US prevalence of arthritis and associated activity limitations, " Arthritis & Rheumatism, vol. 54, no. 1, pp. 226-229, 2006.
159. C. A. Hitchon and H. S. El-Gabalawy, "Oxidation in rheumatoid arthritis, " Arthritis Research & Therapy, vol. 6, no. 6, pp. 265-278, 2004.
160. J. Fay, D. Varoga, C. J. Wruck, B. Kurz, M. B. Goldring, and T. Pufe, "Reactive oxygen species induce expression of vascular endothelial growth factor in chondrocytes and human articular cartilage explants, " Arthritis Research & Therapy, vol. 8, article R189, 2006.
161. I. B. McInnes and G. Schett, "Cytokines in the pathogenesis of rheumatoid arthritis, " Nature Reviews Immunology, vol. 7, no. 6, pp. 429-442, 2007.
162. S.-A. Yoo, S.-K. Kwok, and W.-U. Kim, "Proinflammatory role of vascular endothelial growth factor in the pathogenesis of rheumatoid arthritis: prospects for therapeutic intervention, " Mediators of Inflammation, vol. 2008, Article ID129873, 6pages, 2008.
163. L. C. Huber, O. Distler, I. Tarner, R. E. Gay, S. Gay, and T. Pap, "Synovial fibroblasts: key players in rheumatoid arthritis, " Rheumatology, vol. 45, no. 6, pp. 669-675, 2006.
164. I. Meinecke, E. Rutkauskaite, S. Gay, and T. Pap, "The role of synovial fibroblasts in mediating joint destruction in rheumatoid arthritis, " Current Pharmaceutical Design, vol. 11, no. 5, pp. 563-568, 2005.
165. C. J. Wruck, A. Fragoulis, A. Gurzynski et al., "Role of oxidative stress in rheumatoid arthritis: insights from the Nrf2-knockout mice, " Annals of the Rheumatic Diseases, vol. 70, no. 5, pp. 844-850, 2011.
166. C. J. Wruck, M. E. Götz, T. Herdegen, D. Varoga, L.-O. Brandenburg, and T. Pufe, "Kavalactones protect neural cells against amyloid peptide-induced neurotoxicity via extracellular signal-regulated kinase 1/2-dependent nuclear factor erythroid 2-related factor 2 activation, " Molecular Pharmacology, vol. 73, no. 6, pp. 1785-1795, 2008.
167. A. K. Jaiswal, "Nrf2 signaling in coordinated activation of antioxidant gene expression, " Free Radical Biology & Medicine, vol. 36, no. 10, pp. 1199-1207, 2004.
168. D. J. Pattison, A. J. Silman, N. J. Goodson et al., "Vitamin C and the risk of developing inflammatory polyarthritis: prospective nested case-control study, " Annals of the Rheumatic Diseases, vol. 63, no. 7, pp. 843-847, 2004.
169. J. R. Cerhan, K. G. Saag, L. A. Merlino, T. R. Mikuls, and L. A. Criswell, "Antioxidant micronutrients and risk of rheumatoid arthritis in a cohort of older women, " American Journal of Epidemiology, vol. 157, no. 4, pp. 345-354, 2003.
170. D. J. Pattison, D. P. M. Symmons, M. Lunt et al., "Dietary risk factors for the development of inflammatory polyarthritis: evidence for a role of high level of red meat consumption, " Arthritis & Rheumatism, vol. 50, no. 12, pp. 3804-3812, 2004.
171. N. Udagawa, S. Kotake, N. Kamatani, N. Takahashi, and T. Suda, "The molecular mechanism of osteoclastogenesis in rheumatoid arthritis, " Arthritis Research, vol. 4, no. 5, pp. 281-289, 2002.
172. S. Y. Bu, M. Lerner, B. J. Stoecker et al., "Dried plum polyphenols inhibit osteoclastogenesis by downregulating NFATc1 and inflammatory mediators, " Calcified Tissue International, vol. 82, no. 6, pp. 475-488, 2008.
173. Y.-H. He, J. Zhou, Y.-S. Wang et al., "Antiinflammatory and antioxidative effects of cherries on Freund's adjuvantinduced arthritis in rats, " Scandinavian Journal of Rheumatology, vol. 35, no. 5, pp. 356-358, 2006.
174. M. G. F. Wahba, B. A. S. Messiha, andA. A. Abo-Saif, "Protective effects of fenofibrate and resveratrol in an aggressive model of rheumatoid arthritis in rats, " Pharmaceutical Biology, vol. 54, no. 9, pp. 1705-1715, 2015.
175. M. Tsubaki, T. Takeda, T. Kino et al., "Mangiferin suppresses CIA by suppressing the expression of TNF-, IL-6, IL-1, and RANKL through inhibiting the activation of NF-B and ERK1/2, " American Journal of Translational Research, vol. 7, no. 8, pp. 1371-1381, 2015.
176. P. Luczkiewicz, A. Kokotkiewicz, A. Dampc, and M. Luczkiewicz, "Mangiferin: A promising therapeutic agent for rheumatoid arthritis treatment, " Medical Hypotheses, vol. 83, no. 5, pp. 570-574, 2014.
177. V. Natarajan, B. Madhan, and M. L. Tiku, "Intra-articular injections of polyphenols protect articular cartilage from inflammation-induced degradation: suggesting a potential role in cartilage therapeutics, " PLoS ONE, vol. 10, no. 6, Article ID e0127165, 20 pages, 2015.
178. H.-Y. Yoon, E.-G. Lee, H. Lee et al., "Kaempferol inhibits IL-1-induced proliferation of rheumatoid arthritis synovial fibroblasts and the production of COX-2, PGE2 and MMPs, " International Journal of Molecular Medicine, vol. 32, no. 4, pp. 971-977, 2013.
179. M. Comalada, D. Camuesco, S. Sierra et al., "In vivo quercitrin anti-inflammatory effect involves release of quercetin, which inhibits inflammation through down-regulation of the NF-B pathway, " European Journal of Immunology, vol. 35, no. 2, pp. 584-592, 2005.
180. G. Schett, M. Tohidast-Akrad, J. S. Smolen et al., "Activation, differential localization, and regulation of the stress-activated protein kinases, extracellular signal-regulated kinase, c-Jun Nterminal kinase, and p38 mitogen-activated protein kinase, in synovial tissue and cells in rheumatoid arthritis, " Arthritis & Rheumatism, vol. 43, no. 11, pp. 2501-2512, 2000.
181. S. J. Pragasam, V. Venkatesan, and M. Rasool, "Immunomodulatory and anti-inflammatory effect of p-coumaric acid, a common dietary polyphenol on experimental inflammation in rats, " Inflammation, vol. 36, no. 1, pp. 169-176, 2013.
182. J. Wang, Q. Zhang, S. Jin, D. He, S. Zhao, and S. Liu, "Genistein modulate immune responses in collagen-induced rheumatoid arthritis model, " Maturitas, vol. 59, no. 4, pp. 405-412, 2008.
183. D. J. Pattison, D. P. M. Symmons, M. Lunt et al., "Dietary-cryptoxanthin and inflammatory polyarthritis: results from a population-based prospective study, " The American Journal of Clinical Nutrition, vol. 82, no. 2, pp. 451-455, 2005.
184. I. Avalos, C. P. Chung, A. Oeser et al., "Increased augmentation index in rheumatoid arthritis and its relationship to coronary artery atherosclerosis, " The Journal of Rheumatology, vol. 34, no. 12, pp. 2388-2394, 2007.
185. A. Cypiene, A. Laucevicius, A. Venalis et al., "Non-invasive assessment of arterial stiffness indices by applanation tonometry andpulsewave analysis inpatientswith rheumatoid arthritis treated with TNF-blocker remicade (infliximab), " Proceedings Western Pharmacology Society, vol. 50, pp. 119-122, 2007.
186. M. A. Crilly and G. McNeill, "Arterial dysfunction in patients with rheumatoid arthritis and the consumption of daily fruits and daily vegetables, " European Journal of ClinicalNutrition, vol. 66, no. 3, pp. 345-352, 2012.
187. G. Ramadan and O. El-Menshawy, "Protective effects of gingerturmeric rhizomes mixture on joint inflammation, atherogenesis, kidney dysfunction and other complications in a rat model of human rheumatoid arthritis, " International Journal of Rheumatic Diseases, vol. 16, no. 2, pp. 219-229, 2013.
188. G. Ramadan, M. A. Al-Kahtani, and W. M. El-Sayed, "Antiinflammatory and anti-oxidant properties of Curcuma longa (turmeric) versus Zingiber officinale (ginger) rhizomes in rat adjuvant-induced arthritis, " Inflammation, vol. 34, no. 4, pp. 291-301, 2011.
189. B. Rathi, S. Bodhankar, V. Mohan, and P. Thakurdesai, "Ameliorative effects of a polyphenolic fraction of Cinnamomum zeylanicum L. bark in animal models of inflammation and arthritis, " Scientia Pharmaceutica, vol. 81, no. 2, pp. 567-589, 2013.
190. B. Kloesch, T. Becker, E. Dietersdorfer, H. Kiener, and G. Steiner, "Anti-inflammatory and apoptotic effects of the polyphenol curcumin on human fibroblast-like synoviocytes, " International Immunopharmacology, vol. 15, no. 2, pp. 400-405, 2013.
191. R. Woodrick and E. M. Ruderman, "Anti-interleukin-6 therapy in rheumatoid arthritis, " Bulletin of the NYU Hospital for Joint Diseases, vol. 68, no. 3, pp. 211-217, 2010.
192. H. Liu and R. M. Pope, "The role of apoptosis in rheumatoid arthritis, " Current Opinion in Pharmacology, vol. 3, no. 3, pp. 317-322, 2003.
193. A. Soultati, G. Mountzios, C. Avgerinou et al., "Endothelial vascular toxicity from chemotherapeutic agents: preclinical evidence and clinical implications, " Cancer Treatment Reviews, vol. 38, no. 5, pp. 473-483, 2012.
194. L. Zeng, Z. Yan, S. Ding, K. Xu, and L. Wang, "Endothelial injury, an intriguing effect of methotrexate and cyclophosphamide during hematopoietic stem cell transplantation in mice, " Transplantation Proceedings, vol. 40, no. 8, pp. 2670-2673, 2008.
195. H. Sankrityayan and A. S. Majumdar, "Curcumin and folic acid abrogated methotrexate induced vascular endothelial dysfunction, " Canadian Journal of Physiology and Pharmacology, vol. 94, no. 1, pp. 89-96, 2015.
196. Z. Zheng, Y. Sun, Z. Liu, M. Zhang, C. Li, andH. Cai, "The effect of curcumin and its nanoformulation on adjuvant-induced arthritis in rats, " Drug Design, Development and Therapy, vol. 9, pp. 4931-4942, 2015.
197. C. Delgado and J.-X. Guinard, "How do consumer hedonic ratings for extra virgin olive oil relate to quality ratings by experts and descriptive analysis ratings" Food Quality and Preference, vol. 22, no. 2, pp. 213-225, 2011.
198. M.Á. Rosillo, M. J. Alcaraz, M. Sánchez-Hidalgo, J. G. Fernández-Bolaños, C. Alarcón-de-la-Lastra, andM. L. Ferrándiz, "Anti-inflammatory and joint protective effects of extra-virgin olive-oil polyphenol extract in experimental arthritis, " Journal of Nutritional Biochemistry, vol. 25, no. 12, pp. 1275-1281, 2014.
199. J. Morel and F. Berenbaum, "Signal transduction pathways: new targets for treating rheumatoid arthritis, " Joint Bone Spine, vol. 71, no. 6, pp. 503-510, 2004.
200. Z. Han, D. L. Boyle, A. M. Manning, and G. S. Firestein, "AP-1 and NF-B regulation in rheumatoid arthritis and murine collagen-induced arthritis, " Autoimmunity, vol. 28, no. 4, pp. 197-208, 1998.
201. S.-Y. Min, M. Yan, S. B. Kim et al., "Green tea epigallocatechin-3-gallate suppresses autoimmune arthritis through indoleamine-2, 3-dioxygenase expressing dendritic cells and the nuclear factor, erythroid 2-like 2 antioxidant pathway, " Journal of Inflammation, vol. 12, no. 1, article 53, 15 pages, 2015.
202. C.-H. Yoon, S.-J. Chung, S.-W. Lee, Y.-B. Park, S.-K. Lee, and M.-C. Park, "Gallic acid, a natural polyphenolic acid, induces apoptosis and inhibits proinflammatory gene expressions in rheumatoid arthritis fibroblast-like synoviocytes, " Joint Bone Spine, vol. 80, no. 3, pp. 274-279, 2013.
203. Y. Oka, S. Iwai, H. Amano et al., "Tea polyphenols inhibit rat osteoclast formation and differentiation, " Journal of Pharmacological Sciences, vol. 118, no. 1, pp. 55-64, 2012.
204. P. S. Burrage, K. S. Mix, and C. E. Brinckerhoff, "Matrix metalloproteinases: role in arthritis, " Frontiers in Bioscience, vol. 11, no. 1, pp. 529-543, 2006.
205. M. D. Mossalayi, J. Rambert, E. Renouf, M. Micouleau, and J. M. Mérillon, "Grape polyphenols and propolis mixture inhibits inflammatory mediator release from human leukocytes and reduces clinical scores in experimental arthritis, " Phytomedicine, vol. 21, no. 3, pp. 290-297, 2014.
206. M. Mueller, S. Hobiger, and A. Jungbauer, "Anti-inflammatory activity of extracts from fruits, herbs and spices, " Food Chemistry, vol. 122, no. 4, pp. 987-996, 2010.